Accelerate Diagnostics Announces New Data for Novel Accelerate Arc™ Module and BC Kit at ECCMID 2022
Healthcare
Stay updated with breaking news from Accelerate Diagnostics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Of the 30 companies in the index, 17 saw declines in their stock prices, while 13 saw share price increases.
The difference between growth and value funds was stark.
Accelerate Diagnostics, Inc. (NASDAQ: AXDX) an in-vitro diagnostics company dedicated to providing solutions for the global challenges of antibiotic resistance and sepsis, today announced the launch of the Accelerate Arc system, comprised of the Arc Module and BC Kit, an automated path to rapid and accurate ...
/PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ: AXDX) an in-vitro diagnostics company dedicated to providing solutions for the global challenges of...